March 8, 2024 Comments Off on New patent expiration for Astrazeneca drug DALIRESP Posted in: Uncategorized
Annual Drug Patent Expirations for DALIRESP Daliresp is a drug marketed by Astrazeneca and is included in one NDA. It is available from one supplier. There are three patents protecting…
The post New patent expiration for Astrazeneca drug DALIRESP appea…
March 8, 2024 Comments Off on New patent expiration for Novartis drug LEQVIO Posted in: Uncategorized
Annual Drug Patent Expirations for LEQVIO Leqvio is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are thirteen patents protecting…
The post New patent expiration for Novartis drug LEQVIO appeared first…
